Command Palette

Search for a command to run...

Clinical Trials · NCT02404376

COMBinAtion Therapy in Myocardial Infarction: The COMBAT-MI Trial

CompletedPhase 3Exenatide (Approved)
Phase
Phase 3
Recruitment status
Completed
Sponsor
Hospital Universitari Vall d'Hebron Research Institute
Enrollment
378
Start date
Mar 2016
Locations
6 sites, Spain
Primary endpoint
Myocardial Infarct Size
View Exenatide compound reference